organophosphonates has been researched along with sesquiterpenes in 10 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (sesquiterpenes) | Trials (sesquiterpenes) | Recent Studies (post-2010) (sesquiterpenes) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 17,489 | 536 | 7,668 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parker, TS; Popják, G; Sutherland, K; Wong, SM | 1 |
| Cermak, DM; Hohl, RJ; Holstein, SA; Lewis, K; Wiemer, DF | 1 |
| Beese, LS; Bond, R; Le, HV; Schwartz, J; Strickland, CL; Syto, R; Wang, L; Weber, PC; Windsor, WT; Wu, Z | 1 |
| Du, Y; Wiemer, DF | 1 |
| Liekens, S | 1 |
| Cornish, K; Garneau, S; Mau, CJ; Scholte, AA; Van Fleet, JE; Vederas, JC | 1 |
| Rowe, BJ; Spilling, CD | 1 |
| Tallman, M | 1 |
| Cisari, C; Invernizzi, M; Migliario, M; Renò, F; Rizzi, M | 1 |
| Borodi, G; Căproiu, MT; Drăghici, C; Gal, E; Hanganu, A; Maganu, M; Pintilie, L; Tănase, CI | 1 |
1 review(s) available for organophosphonates and sesquiterpenes
| Article | Year |
|---|---|
The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cidofovir; Cyclohexanes; Cytosine; Disease Models, Animal; Fibroblast Growth Factor 2; Growth Substances; Hemangioma; Humans; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Organophosphonates; Organophosphorus Compounds; Rats; Sesquiterpenes; Thymidine Phosphorylase; Tumor Virus Infections | 2002 |
9 other study(ies) available for organophosphonates and sesquiterpenes
| Article | Year |
|---|---|
Inhibition of liver prenyltransferase by alkyl phosphonates and phosphonophosphates.
Topics: Animals; Binding Sites; Cholesterol; Dimethylallyltranstransferase; Farnesol; Kinetics; Liver; Mevalonic Acid; Organophosphonates; Polyisoprenyl Phosphates; Sesquiterpenes; Structure-Activity Relationship; Swine; Transferases | 1978 |
Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase.
Topics: Alkyl and Aryl Transferases; Animals; Brain; Cattle; Enzyme Inhibitors; Organophosphonates; Polyisoprenyl Phosphates; Sesquiterpenes; Structure-Activity Relationship | 1998 |
Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue.
Topics: Alkyl and Aryl Transferases; Animals; Binding Sites; Crystallization; Crystallography, X-Ray; Farnesol; Humans; Macromolecular Substances; Models, Molecular; Oligopeptides; Organophosphonates; Polyisoprenyl Phosphates; Protein Structure, Secondary; Protein Structure, Tertiary; Rats; Sesquiterpenes; Substrate Specificity | 1998 |
Alpha-phosphono lactone analogues of farnesyl pyrophosphate: an asymmetric synthesis via ring-closing metathesis.
Topics: Ether; Farnesol; Furans; Indicators and Reagents; Isomerism; Lactones; Molecular Conformation; Organophosphonates; Polyisoprenyl Phosphates; Sesquiterpenes; Structure-Activity Relationship | 2002 |
Protein farnesyltransferase inhibitors interfere with farnesyl diphosphate binding by rubber transferase.
Topics: Alkyl and Aryl Transferases; Asteraceae; Binding Sites; Dimethylallyltranstransferase; Enzyme Inhibitors; Farnesol; Farnesyltranstransferase; Glutarates; Hevea; Kinetics; Lithium Compounds; Maleates; Organophosphonates; Polyisoprenyl Phosphates; Salts; Sesquiterpenes; Solvents; Species Specificity | 2003 |
Stereospecific Pd(0)-catalyzed arylation of an allylic hydroxy phosphonate derivative: formal synthesis of (S)-(+)-ar-turmerone.
Topics: Allyl Compounds; Catalysis; Ketones; Models, Chemical; Molecular Structure; Organophosphonates; Palladium; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship; Toluene | 2003 |
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.
Topics: Adenine; Adenine Nucleotides; Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arabinonucleosides; Carbazoles; Clofarabine; Cytarabine; Dasatinib; Daunorubicin; fms-Like Tyrosine Kinase 3; Furans; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Naphthalimides; Organophosphonates; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Sesquiterpenes; Staurosporine; Stem Cell Transplantation; Thiazoles; Tretinoin | 2008 |
Low doses amino-bisphosphonates stimulate keratinocytes growth inactivating glucocorticoid receptor.
Topics: Adult; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Keratinocytes; Organophosphonates; Polyisoprenyl Phosphates; Receptors, Glucocorticoid; Sesquiterpenes | 2013 |
β-Ketophosphonates with Pentalenofuran Scaffolds Linked to the Ketone Group for the Synthesis of Prostaglandin Analogs.
Topics: Chemistry Techniques, Synthetic; Crystallography, X-Ray; Ketones; Models, Molecular; Molecular Conformation; Molecular Structure; Organophosphonates; Prostaglandins, Synthetic; Sesquiterpenes | 2021 |